Genetically programmed chiral organoborane synthesis by Kan, S. B. Jennifer et al.
 	
Genetically programmed chiral organoborane synthesis 
S. B. Jennifer Kan,† Xiongyi Huang,† Yosephine Gumulya, Kai Chen, 
 and Frances H. Arnold* 
Division of Chemistry and Chemical Engineering, California Institute of Technology, 
1200 East California Boulevard, MC 210-41, Pasadena, CA 91125, United States 
Email: frances@cheme.caltech.edu 
† = These authors contributed equally to this work. 
This PDF includes: 
I. Materials and Methods 2 
II. Kinetics Studies 3-4
III. Inhibition Studies 4
IV. Substrate Synthesis and Characterization 4-6
V. Synthesis and Characterization of Authentic Organoborane Products 6-9
VI. GC-MS Standard Curves for Organoborane Products 10-15
VII. Determination of Enantioselectivity 16-25
VIII. Preparative Scale Enzymatic Reactions 26-27
IX. Derivatization of Enzymatic Borylation Product 18 28-30
X. NMR Spectra 31-56
XI. X-ray Crystallography and the Assignments of Absolute Configuration 57-63
XII. Supplemental References 64-65
SUPPLEMENTARY INFORMATION
doi:10.1038/nature24996
WWW.NATURE.COM/NATURE | 1
I. Materials and Methods
Unless otherwise noted, all chemicals and reagents were obtained from commercial 
suppliers (Sigma-Aldrich, VWR, Alfa Aesar, Acros) and used without further purification. Bovine 
serum albumin (BSA) was purchased from Sigma-Aldrich. Silica gel chromatography was carried 
out using AMD Silica Gel 60, 230-400 mesh. 1H and 13C NMR spectra were recorded on a Bruker 
Prodigy 400 MHz instrument (400 MHz for 1H and 100 MHz for 13C). Chemical shifts (δ) are 
reported in ppm downfield from tetramethylsilane, using the solvent resonance as the internal 
standard (1H NMR:  δ = 7.26, 13C NMR:  δ = 77.36 for CDCl3). 19F NMR and 11B NMR data were 
collected on a VARIAN 300 MHz spectrometer (101 MHz for 19F NMR) and a Bruker Prodigy 
400 MHz instrument (128 MHz for 11B NMR), respectively. Sonication was performed using a 
Qsonica Q500 sonicator. High-resolution mass spectra were obtained at the California Institute of 
Technology Mass Spectral Facility. Chemical reactions were monitored using thin layer 
chromatography (Merck 60 gel plates) using a UV-lamp for visualization. Gas chromatography 
(GC) analyses were carried out using a Shimadzu GC-17A gas chromatograph, a FID detector, 
and J&W HP-5 column (30 m x 0.32 mm, 0.25 µm film). Gas chromatography-mass spectrometry 
(GC-MS) analyses were carried out using Shimadzu GCMS-QP2010SE system and J&W HP-5ms 
column. Analytical chiral supercritical fluid chromatography (SFC) was performed with a JACSO 
2000 series instrument using i-PrOH and supercritical CO2 as the mobile phase. Chiral normal-
phase HPLC analyses were performed using an Agilent 1200 series instrument with i-PrOH and 
hexanes as the mobile phase. Chiral GC was performed on an Agilent 6850 GC with FID detector 
using a Chiraldex GTA column (30.0 m × 0.25 mm) at 1.0 mL/min He carrier gas flow.  
Biological materials and methods are described in the Methods section of the manuscript. 
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II. Kinetic Studies
Comparison of carbon–boron bond forming rates of BORWT and BORR1 as whole-cell
catalysts, cell lysates, or purified proteins. 
Biocatalysts turnover frequency (TOF) / h–1 
BORWT purified protein 3 ± 2 
BORWT cell lysate 4 ± 1 
BORWT whole cell 410 ± 250 
BORR1 purified protein 30 ± 2 
BORR1 cell lysate 160 ± 100 
BORR1 whole cell 6100 ± 700 
      TOFs reported represent mean values averaged over four experiments. Errors quoted indicate 
one standard deviation. 
Whole cell-catalysed reaction: Experiments were performed using whole E. coli cells 
harbouring BORWT or BORR1 (with the BOR protein concentration normalised to 10 µM), 10 mM 
borane, 10 mM diazo ester, 5 vol% MeCN, M9-N buffer at room temperature under anaerobic 
conditions for various time intervals.  
Cell lysate-catalysed reaction: Experiments were performed using cell lysate of E. coli 
harbouring BORWT or BORR1 (with the BOR protein concentration normalised to 10 µM), 10 mM 
borane, 10 mM diazo ester, 10 mM Na2S2O4, 5 vol% MeCN, M9-N buffer at room temperature 
under anaerobic conditions for various time intervals. See Methods section of the manuscript for 
cell lysate preparation procedure.  
Purified protein-catalysed reaction: Experiments were performed using purified BORWT 
or BORR1 (10 µM), 10 mM borane, 10 mM diazo ester, 10 mM Na2S2O4, 5 vol% MeCN, M9-N 
buffer at room temperature under anaerobic conditions for various time intervals. See Methods 
section of the manuscript for purified protein preparation procedure 
General procedure for carrying out timed experiments: In an anaerobic chamber, 3.8 
mL of whole E. coli cells harboring BOR variant, or a solution of 3.4 mL of BOR variant cell 
lysate / purified protein and 0.4 mL Na2S2O4 (100 mM in M9-N buffer), was added to a 10 mL 
glass vial. After charging NHC-borane 1 (100 µL, 400 mM in MeCN) and Me-EDA 2 (100 µL, 
400 mM in MeCN), the vial was capped and the reaction was shaken at 600 rpm on an orbital 
shaker. At regular time intervals (see table below), 400 µL of the reaction mixture was removed 
from the vial and added to a 2 mL microcentrifuge tube containing 600 µL cyclohexane / EtOAc 
Me
N2
O
OEt+
E. coli harbouring
Rma cyt c variant
Me
BH2
O
OEtN
N
BH3
N
N
M9-N buffer (pH 7.4)
room temperature
Me-EDA (2)NHC-borane (1) 3
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(1:1 v/v) and internal standard (20 µL, 20 mM 1,2,3-trimethoxybenzene in toluene). After 
vortexing for 20 seconds, 200 µL of the organic layer was immediately removed for GC analysis. 
Biocatalysts Sampling time 
BORWT purified protein Every hour from t = 1 to 4 h 
BORWT cell lysate Every hour from t = 1 to 4 h 
BORWT whole cell Every minute from t = 1 to 4 min 
BORR1 purified protein Every minute from t = 1 to 4 min 
BORR1 cell lysate Every minute from t = 0.5 to 3.5 min 
BORR1 whole cell Every minute from t = 0.5 to 3.5 min 
Table above shows time points at which the biocatalytic reaction was sampled to determine the 
reaction initial rate.  
III. Inactivation Studies
Inactivation studies of BORR1 were carried out using purified protein or whole cell E. coli 
harbouring BORR1. Effects of NHC-borane 1, Me-EDA 2, or organoborane 3 were determined 
by preincubating the biocatalyst with either one of these reagents (10 mM) for 15 min before the 
catalyst was used for borylation, and by comparing the TTN of the resulting catalyst (TTNincub) 
with that of an untreated biocatalyst (TTNcontrol), as described in Figure 2f.  
Purified protein-catalysed reactions were performed using purified BORR1 (10 µM), 10 
mM borane, 10 mM diazo ester, 10 mM Na2S2O4, 5 vol% MeCN, M9-N buffer at room 
temperature under anaerobic conditions for 30 min. See Methods section of the manuscript for 
purified protein preparation procedure 
Whole cell-catalysed reactions were performed using whole E. coli cells harboring BORR1 
(with the BOR protein concentration normalised to 10 µM), 10 mM borane, 10 mM diazo ester, 5 
vol% MeCN, M9-N buffer at room temperature under anaerobic conditions for 30 min.  
IV. Substrate Synthesis and Characterization
Picoline borane substrate was obtained from Sigma-Aldrich. Ethyl 2-diazopropanoate (Me-
EDA) was obtained from Arch Bioscience. All commercially available reagents were used as 
received. The following diazo compounds are known and prepared according to literature 
procedures: methyl 2-diazopropanoate 1 , isopropyl 2-diazopropanoate 2 , benzyl 2-diazopro-
panoate3, ethyl 2-phenyldiazoacetate (Ph-EDA)4, ethyl 2-diazo-3,3,3-trifluoropropanoate (CF3-
EDA)5, and (1-diazo-2,2,2-trifluoroethyl)benzene (CF3-DMB)6. 
Other NHC-BH3 substrates were synthesized from corresponding imidazolium iodide salts 
as reported7. Namely, imidazolium iodide salts (5 mmol) were resuspended in 5 mL THF.  A 
solution of NaHMDS (1M in THF, 1.05 equiv.) was then added at ‒78 oC under Ar and shaken for 
1 h at ‒78 oC. Afterwards, a solution of BH3-THF (1M in THF, 1 equiv.) was added to the reaction 
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and the reaction mixture was allowed to warm from ‒78 oC to rt and stirred overnight. The solvent 
was removed under reduced pressure and the residue was purified by flash column 
chromatography to give the NHC-BH3 complexes. The 1H NMR resonances of the B‒H protons 
are broad (due to geminal coupling with boron) and generally in the range of 0.4 – 1.6 ppm. The
13C NMR resonances of the boron-binding NHC quarternary carbons usually appear at around 170 
ppm and are typically broad (due to germinal coupling with boron) and weak; these signals are 
sometimes not visible in the 13C NMR spectra.  
This compound is known8. 1H NMR (400 MHz, Chloroform-d) δ 6.91 – 
6.66 (m, 2H), 3.71 (s, 6H), 0.99 (dd, J = 172.7, 86.3 Hz, 3H).  
This compound is known9. 1H NMR (400 MHz, Chloroform-d) δ 6.87 – 
6.65 (m, 2H), 4.00 (q, J = 7.3 Hz, 2H), 3.57 (s, 3H), 1.22 (t, J = 7.3 Hz, 
3H), 1.44 – 0.30 (m, 3H). 
This compound is known8. 1H NMR (400 MHz, Chloroform-d) δ 6.84 – 
6.79 (m, 2H), 5.91 (ddt, J = 17.1, 10.2, 6.1 Hz, 1H), 5.30 – 5.06 (m, 2H), 
4.71 (dt, J = 6.1, 1.5 Hz, 2H), 3.71 (s, 3H), 1.43 – 0.35 (m, 3H). 
1H NMR (400 MHz, Chloroform-d) δ 6.82 – 6.76 (m, 2H), 4.13 – 3.97 (m, 
2H), 3.69 (s, 3H), 1.83 – 1.63 (m, 2H), 1.42 – 1.19 (m, 6H), 0.97 – 0.75 (m, 
3H), 1.46 – 0.41 (m, 3H); 13C NMR (101 MHz, CDCl3) δ 171.0, 119.9, 118.7, 
48.8, 35.8, 31.3, 30.1, 26.1, 22.5, 14.0; 11B NMR (128 MHz, Chloroform-d) 
δ ‒37.4 (q, J = 86 Hz); MS (FAB) m/z [(M + H)+ ‒ H2] calcd for C10H20N2B: 
179.1720, found: 179.1707. 
This compound is known8. 1H NMR (400 MHz, Chloroform-d) δ 7.85 (s, 
1H), 3.94 (s, 3H), 3.74 (s, 3H), 1.45 – 0.42 (m, 3H). 
This compound is known10. 1H NMR (400 MHz, Chloroform-d) δ 6.49 (q, J 
= 1.2 Hz, 1H), 3.56 (s, 3H), 3.50 (s, 3H), 2.07 (d, J = 1.3 Hz, 3H), 1.31 – 
0.43 (m, 3H). 
This compound is known11. 1H NMR (400 MHz, Chloroform-d) δ 3.72 (s, 
6H), 1.44 – 0.41 (m, 3H). 
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1H NMR (400 MHz, Chloroform-d) δ 7.23 (q, J = 1.5 Hz, 1H), 3.82 (s, 3H), 
3.77 (s, 3H), 1.49 – 0.54 (m, 3H). 13C NMR (101 MHz, CDCl3) δ 177.1, 
122.2, 121.8, 119.40 (q, J = 267.3 Hz), 36.5, 34.0. 11B NMR (128 MHz, 
Chloroform-d) δ ‒37.4 (q, J = 88 Hz). 19F NMR (282 MHz, Chloroform-d) δ 
‒61.2 (d, J = 3 Hz); MS (FAB) m/z [(M+H)+‒H2] calcd for C6H9F3N2B: 
177.0811, found: 177.0815. 
1H NMR (400 MHz, Chloroform-d) δ 6.78 (s, 1H), 3.71 (s, 3H), 3.67 (s, 3H), 
1.45 – 0.51 (m, 3H). 13C NMR (101 MHz, CDCl3) δ 13C NMR (101 MHz, 
CDCl3) δ 173.5, 119.3, 116.9, 36.4, 33.0. 11B NMR (128 MHz, Chloroform-
d) δ ‒36.9 (q, J = 87 Hz); MS (FAB) m/z [(M+H)+‒H2] calcd for C5H9N2BCl: 
143.0547, found: 143.0547. 
V. Synthesis and Characterization of Authentic Organoborane Products
Racemic standard references of organoborane products were prepared via Rh-catalyzed B‒
H insertion reactions with procedures slightly modified from a previously reported method8. 
Namely, a 4 mL vial with screw cap and PTFE septum was charged with a borane substrate (1.0 
mmol, 1 equiv.) and Rh2(OAc)4 (11 mg, 2.5 mol%). The vial was evacuated and backfilled with 
Ar three times and 2 mL of anhydrous CH2Cl2 was added. The vial was placed in a 38 oC water 
bath. A CH2Cl2 solution (1 mL) of diazo compound (1.0 mmol) was slowly added to the reaction 
mixture over 4 hours. Afterwards, the reaction mixture was allowed to further react overnight. The 
crude reaction mixture was purified by flash chromatography (dry loading) using EtOAc and 
hexanes as eluents and afforded organoborane products in 30 - 75% yield. The 1H NMR resonances 
of the B‒H protons are broad (due to geminal coupling with boron) and generally in the range of 
0.4 – 1.6 ppm. The 13C NMR resonances of the boron-binding NHC quarternary carbons usually
appear at around 170 ppm and are typically broad (due to germinal coupling with boron) and weak; 
these signals are sometimes not visible in the 13C NMR spectra. 
(1,3-Dimethyl-1H-imidazol-3-ium-2-yl)(1-ethoxy-1-oxopropan-2-yl)dihydroborate (3) 
1H NMR (400 MHz, Chloroform-d) δ 6.82 (s, 2H), 3.98 – 3.78 (m, 2H), 3.75 (s, 
6H), 1.95 – 1.10 (m, 2H), 1.88 (br s, 1H), 1.10 (d, J = 6.2 Hz, 3H), 1.06 (t, J = 
7.1 Hz, 3H); 13C NMR (101 MHz, Chloroform-d) δ 183.5, 120.4, 58.7, 36.2, 30.5, 
17.8, 14.6. The boron-bound NHC quarternery carbon was not resolved; 11B 
NMR (128 MHz, Chloroform-d) δ ‒24.6 (t, J = 90 Hz); MS (FAB) m/z [(M + H)
+ ‒ H2] calcd for C10H18O2N2B: 209.1461, found: 209.1456.
(1-Ethoxy-1-oxopropan-2-yl)(3-ethyl-1-methyl-1H-imidazol-3-ium-2-yl)dihydroborate (4) 
1H NMR (400 MHz, Chloroform-d) δ 6.91 – 6.82 (m, 2H), 4.28 – 3.97 (m, 2H), 
3.93 – 3.73 (m, 2H), 3.70 (s, 3H), 1.84 (br s, 1H), 1.95 – 1.10 (br m, 2H), 1.34 (t, 
J = 7.3 Hz, 3H), 1.05 (d, J = 6.7 Hz, 3H), 0.98 (t, J = 7.2 Hz, 3H); 13C NMR (101 
MHz, Chloroform-d) δ 183.3, 170.0, 120.7, 118.2, 58.4, 43.5, 35.9, 30.4, 17.6, 
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15.8, 14.4; 11B NMR (128 MHz, Chloroform-d) δ –24.5 (t, J = 89 Hz). MS (FAB) m/z [M+·] calcd 
for C11H21O2N2B: 224.1696, found: 224.1693. 
(3-Allyl-1-methyl-1H-imidazol-3-ium-2-yl)(1-ethoxy-1-oxopropan-2-yl)dihydroborate (5) 
1H NMR (400 MHz, Chloroform-d) δ 6.85 (AB q, J = 2.0 Hz, 2H), 5.94 (ddt, J = 
17.1, 10.2, 6.1 Hz, 1H), 5.39 – 5.17 (m, 2H), 4.82 (ddt, J = 15.3, 6.0, 1.5 Hz, 1H), 
4.68 (ddt, J = 15.3, 6.2, 1.4 Hz, 1H), 3.99 – 3.78 (m, 2H), 3.76 (s, 3H), 1.92 – 1.05 
(m, 2H), 1.87 (br s, 1H), 1.09 (d, J = 6.6 Hz, 3H), 1.05 (t, J = 7.1 Hz, 3H); 13C 
NMR (101 MHz, Chloroform-d) δ 183.6, 132.9, 120.9, 119.7, 119.0, 58.8, 51.4, 
36.4, 32.0, 17.9, 14.8. The boron-bound NHC quarternery carbon was not resolved; 
11B NMR (128 MHz, Chloroform-d) δ –24.6 (t, J = 90 Hz). MS (FAB) m/z [M + 
H+] calcd for C12H22O2N2B: 237.1774, found: 237.1783. 
(1-Ethoxy-1-oxopropan-2-yl)(3-hexyl-1-methyl-1H-imidazol-3-ium-2-yl)dihydroborate (6) 
1H NMR (400 MHz, Chloroform-d) δ 6.88 – 6.79 (m, 2H), 4.20 – 4.06 (m, 
1H), 3.99 (m, 1H), 3.93 – 3.74 (m, 2H), 3.72 (s, 3H), 1.93 – 1.79 (m, 1H), 
1.72 (dt, J = 13.8, 6.9 Hz, 2H), 1.71 – 1.20 (m, 8H), 1.12 – 1.05 (m, 3H), 1.01 
(td, J = 7.2, 2.4 Hz, 3H), 0.90 – 0.80 (m, 3H); 13C NMR (101 MHz, 
Chloroform-d) δ 183.6, 120.7, 119.0, 58.7, 48.9, 36.2, 31.6, 30.8, 30.5, 26.5, 
22.7, 17.9, 14.7, 14.2. The boron-bound NHC quarternery carbon was not 
resolved; 11B NMR (128 MHz, Chloroform-d) δ –24.5 (t, J = 90 Hz); MS (FAB) m/z [M+·] calcd for 
C15H29O2N2B: 280.2322, found: 280.2330. 
(1-Ethoxy-1-oxopropan-2-yl)(1,3,4-trimethyl-1H-imidazol-3-ium-2-yl)dihydroborate (7) 
1H NMR (400 MHz, Chloroform-d) δ 6.55 (q, J = 1.2 Hz, 1H), 3.95 – 3.77 (m, 
2H), 3.66 (s, 3H), 3.61 (s, 3H), 2.16 (d, J = 1.1 Hz, 3H), 1.84 (br s, 1H), 1.93 – 
1.10 (m, 2H), 1.07 (s, 3H), 1.12 – 1.02 (m, 3H); 13C NMR (101 MHz, Chloroform-
d) δ 183.7, 170.0, 128.3, 117.6, 58.7, 35.9, 32.7, 32.0 – 29.5 (m), 17.9, 14.7, 9.7; 
11B NMR (128 MHz, Chloroform-d) δ –24.2 (t, J = 89 Hz); MS (FAB) m/z [M+·]
calcd for C11H21O2N2B: 224.1696, found: 224.1695. 
(1,3-Dimethyl-4-(trifluoromethyl)-1H-imidazol-3-ium-2-yl)(1-ethoxy-1-oxopropan-2-
yl)dihydroborate (8) 
1H NMR (400 MHz, Chloroform-d) δ 7.29 (q, J = 1.3 Hz, 1H), 4.00 – 3.70 (m, 
2H), 3.85 (s, 3H), 3.81 (s, 3H), 1.88 (br s, 1H), 1.85 – 1.05 (m, 2H), 1.12 (d, J = 
6.6 Hz, 3H), 1.05 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, Chloroform-d) δ 
183.2, 123.6, 122.8 – 122.5 (m), 119.6 (q, J = 267.6 Hz), 59.0, 36.9, 34.4, 30.0, 
17.9, 14.7. The boron-bound NHC quarternery carbon was not resolved; 11B 
NMR (128 MHz, Chloroform-d) δ –24.7 (t, J = 91 Hz). 19F NMR (282 MHz, 
Chloroform-d) δ –61.1; MS (FAB) m/z [M+·] calcd for C11H18O2N2BF3: 
278.1414, found: 278.1405. 
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(4-Chloro-1,3-dimethyl-1H-imidazol-3-ium-2-yl)(1-ethoxy-1-oxopropan-2-yl)dihydroborate 
(9) 
1H NMR (400 MHz, Chloroform-d) δ 6.83 (s, 1H), 3.97 – 3.79 (m, 2H), 3.73 
(s, 3H), 3.70 (s, 3H), 2.00 – 1.10 (m, 2H), 1.94 – 1.76 (m, 1H), 1.13 – 1.02 (m, 
6H); 13C NMR (101 MHz, Chloroform-d) δ 183.4, 173.0, 119.9, 117.3, 58.9, 
36.6, 33.3, 30.3, 17.9, 14.7; 11B NMR (128 MHz, Chloroform-d) δ –24.2 (t, J 
= 90 Hz); MS (FAB) m/z [M+·] calcd for C10H18O2N2BCl: 244.1150, found: 
244.1154. 
(4,5-Dichloro-1,3-dimethyl-1H-imidazol-3-ium-2-yl)(1-ethoxy-1-oxopropan-2-
yl)dihydroborate (10) 
1H NMR (400 MHz, Chloroform-d) δ 3.95 – 3.78 (m, 2H), 3.72 (s, 6H), 1.83 
(br s, 1H), 1.99 – 1.05 (m, 2H), 1.10 (d, J = 11.9 Hz, 3H), 1.05 (t, J = 7.1 Hz, 
3H); 13C NMR (101 MHz, Chloroform-d) δ 183.1, 172.0, 116.6, 59.0, 34.1, 
30.0, 17.8, 14.7; 11B NMR (128 MHz, Chloroform-d) δ –23.9 (t, J = 91 Hz); 
MS (FAB) m/z [M + H+] calcd for C10H18O2N2BCl2: 279.0838, found: 279.0846. 
(1,4-Dimethyl-4H-1,2,4-triazol-1-ium-5-yl)(1-ethoxy-1-oxopropan-2-yl)dihydroborate (11) 
1H NMR (400 MHz, Chloroform-d) δ 7.92 (s, 1H), 3.95 (s, 3H), 3.94 – 3.79 (m, 
2H), 3.78 (s, 3H), 1.89 (br s, 1H), 2.00 – 1.05 (m, 2H), 1.13 – 1.09 (m, 3H), 1.05 
(t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, Chloroform-d) δ 183.2, 141.7, 59.0 (d, J 
= 8.0 Hz), 38.6, 34.1, 30.0, 17.9, 14.7. The boron-bound NHC quarternery carbon 
was not resolved; 11B NMR (128 MHz, Chloroform-d) δ –25.0 (t, J = 91 Hz). MS 
(FAB) m/z [M + H+] calcd for C9H19O2N3B: 212.1570, found: 212.1570. 
Ethyl 2-((2-methyl-pyridin-1-yl)boraneyl)propanoate (12) 
1H NMR (400 MHz, Chloroform-d) δ 8.53 (dd, J = 6.0, 1.6 Hz, 1H), 7.84 (td, J 
= 7.7, 1.7 Hz, 1H), 7.42 – 7.36 (m, 1H), 7.33 – 7.28 (m, 1H), 3.79 (AB qq, J = 
10.8, 7.1 Hz, 2H), 3.30 – 2.15 (m, 2H), 2.77 (s, 3H), 2.05 – 1.92 (m, 1H), 1.05 
(d, J = 6.8 Hz, 3H), 0.94 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, Chloroform-
d) δ 182.1, 157.9, 149.4, 140.2, 127.7, 122.6, 58.8, 32.8, 22.8, 15.2, 14.6; 11B 
NMR (128 MHz, Chloroform-d) δ –5.1 (t, J = 103 Hz); MS (FAB) m/z [M+·] calcd 
for C11H18O2NB: 207.1431, found: 207.1431. 
(1,3-Dimethyl-1H-imidazol-3-ium-2-yl)(1-methoxy-1-oxopropan-2-yl)dihydroborate (13) 
1H NMR (400 MHz, Chloroform-d) δ 6.82 (s, 1H), 3.72 (s, 6H), 3.43 (s, 2H), 
1.99 – 1.08 (m, 3H), 1.06 (d, J = 6.8 Hz, 2H); 13C NMR (101 MHz, Chloroform-
d) δ 183.9, 170.0, 120.6, 50.7, 36.2, 30.5, 17.8; 11B NMR (128 MHz, 
Chloroform-d) δ –24.6 (t, J = 90 Hz); MS (FAB) m/z [M+·] calcd for C9H17O2N2B: 
196.1383, found: 196.1388. 
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(1,3-Dimethyl-1H-imidazol-3-ium-2-yl)(1-isopropoxy-1-oxopropan-2-yl)dihydroborate (14) 
1H NMR (400 MHz, Chloroform-d) δ 6.81 (s, 2H), 4.76 (hept, J = 6.2 Hz, 1H), 
3.75 (s, 6H), 1.86 (br s, 1H), 2.00 – 1.10 (m, 2H), 1.09 (d, J = 6.2 Hz, 6H), 0.94 
(d, J = 6.3 Hz, 3H); 13C NMR (101 MHz, Chloroform-d) δ 183.3, 170.0, 120.6, 
65.1, 36.4, 30.7, 22.5, 22.2, 18.1; 11B NMR (128 MHz, Chloroform-d) δ –24.5 
(t, J = 90 Hz); MS (FAB) m/z [M+·] calcd for C11H21O2N2B: 224.1696, found: 
224.1703. 
(1-(Benzyloxy)-1-oxopropan-2-yl)(1,3-dimethyl-1H-imidazol-3-ium-2-yl)dihydroborate (15) 
1H NMR (400 MHz, Chloroform-d) δ 7.36 – 7.17 (m, 5H), 6.71 (s, 2H), 4.92 (s, 
2H), 3.62 (s, 6H), 2.10 – 1.15 (m, 2H), 1.97 (br s, 1H), 1.16 (d, J = 6.5 Hz, 3H); 
13C NMR (101 MHz, Chloroform-d) δ 183.2, 170.0, 137.6, 128.4, 128.1, 127.7, 
120.5, 64.7, 36.1, 30.8, 17.9; 11B NMR (128 MHz, Chloroform-d) δ –24.5 (t, J 
= 88 Hz); MS (FAB) m/z [(M + H) + ‒ H2] calcd for C15H20O2N2B: 271.1618, 
found: 271.1616. 
(1,3-Dimethyl-1H-imidazol-3-ium-2-yl)(3-ethoxy-1,1,1-trifluoro-3-oxopropan-2-
yl)dihydroborate (16) 
1H NMR (400 MHz, Chloroform-d) δ 6.88 (s, 2H), 4.15 – 3.97 (m, 2H), 3.76 (s, 
6H), 2.65 (s, 1H), 2.10 – 1.25 (m, 2H), 1.18 (t, J = 7.1 Hz, 3H); 13C NMR (101 
MHz, Chloroform-d) δ 174.2 (d, J = 5.2 Hz), 168.0, 128.7 (q, J = 276.2 Hz), 121.2, 
60.0, 42.6, 36.3, 14.6; 11B NMR (128 MHz, Chloroform-d) δ –28.6 (t, J = 92 Hz). 
19F NMR (282 MHz, Chloroform-d) δ –62.5 (d, J = 10 Hz); MS (FAB) m/z [(M + 
H) + ‒ H2] calcd for C10H15O2N2BF3: 263.1179, found: 263.1167.
(1,3-Dimethyl-1H-imidazol-3-ium-2-yl)(2-ethoxy-2-oxo-1-phenylethyl)dihydroborate (17) 
1H NMR (400 MHz, Chloroform-d) δ 7.35 – 7.24 (m, 2H), 7.19 – 7.11 (m, 2H), 
7.07 – 6.99 (m, 1H), 6.77 (s, 2H), 4.24 – 3.93 (m, 2H), 3.46 (s, 6H), 3.35 – 3.22 (m, 
1H), 2.34 – 1.41 (m, 2H), 1.21 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, 
Chloroform-d) δ 179.7, 145.8, 127.9, 127.8, 124.1, 120.7, 120.2, 59.3, 45.6 (d, J = 
44.3 Hz), 36.0, 14.8, (the NHC quarternary carbon was too broad to be visible due 
to coupling with B); 11B NMR (128 MHz, Chloroform-d) δ –23.2 (t, J = 93 Hz); 
MS (FAB) m/z [M+·] calcd for C15H21O2N2B: 272.1696, found: 272.1687. 
(1,3-Dimethyl-1H-imidazol-3-ium-2-yl)(2,2,2-trifluoro-1-phenylethyl)dihydroborate (18) 
1H NMR (400 MHz, Chloroform-d) δ 7.23 – 7.05 (m, 5H), 6.76 (s, 2H), 3.52 (s, 6H), 
2.90 – 2.60 (m, 1H), 2.25 – 1.40 (m, 2H); 13C NMR (101 MHz, Chloroform-d) δ 
169.1, 143.7 (d, J = 3.5 Hz), 131.4 (q, J = 278.0 Hz), 128.4, 128.3, 125.2, 120.8, 43.5, 
36.0; 11B NMR (128 MHz, Chloroform-d) δ ‒26.7 (t, J = 90 Hz); 19F NMR (282 MHz, 
Chloroform-d) δ –61.8 (d, J = 13 Hz); MS (ESI) m/z [M + H+] calcd for C13H17N2BF3: 
269.1437, found: 269.1440. 
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VI. GC-MS Standard Curves for Organoborane Products
Product formation in enzymatic reactions was quantified by GC-MS based on standard 
curves. To determine the standard calibration curves, stock solutions of chemically synthesized 
organoborane products were prepared at various concentrations (1 - 7 mM in 4:6 hexanes/EtOAc) 
with added internal standard 1,2,3-trimethoxybenzene with a final concentration of 6.45 mM in 
the stock solutions of organoborane products. Individual data point for each duplicate run is 
marked as triangle, the average of duplicate runs is marked as red dot. The standard curves plot 
product concentration in mM (y-axis) against the average ratio of product area to internal standard 
area on GC-MS (x-axis). The quantification of organoborane 12 was determined by preparative 
scale reactions as this compound cannot be identified by GC-MS. 
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VII. Determination of Enantioselectivity
All e.r. values of enzymatically synthesized borane products were determined using chiral 
SFC or normal-phase chiral HPLC. The absolute configurations of enzymatically synthesized 
borane products 3, 12, and 18 were determined to be R via X-ray crystallography. The absolute 
configurations of organoborane products 4-11, 13-16 were inferred by analogy, assuming the facial 
selectivity of the diazo reagents from which these products were made remains the same as that of 
Me-EDA.  
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VIII. Preparative Scale Enzymatic Reactions
Preparation of whole-cell suspensions for borylation reactions: HBamp/chlor (200 mL) in
a 1 L flask was inoculated with an overnight culture (4 mL, LBamp/chlor) of recombinant E. cloni® 
EXPRESS BL21(DE3) cells containing a pET22b(+) plasmid encoding Rma cyt c variant, and the 
pEC86 plasmid. The culture was shaken at 37 °C and 250 rpm (no humidity control) until the 
OD600 was 0.7 (typically 2 - 3 hours). The culture was placed on ice for 30 minutes, and IPTG and 
ALA were added to final concentrations of 20 µM and 200 µM, respectively. The incubator 
temperature was reduced to 20 °C, and the culture was allowed to shake for 22 hours at 140 rpm. 
Cells were pelleted by centrifugation (4 °C, 5 min, 4,000xg), resuspended in M9-N buffer and 
adjusted to OD600 = 30. The whole-cell suspension was placed on ice and bubbled with Ar for 30 
min. 
 Biocatalytic synthesis of (1,3-dimethyl-1H-imidazol-3-ium-2-yl)(1-
ethoxy-1-oxopropan-2-yl)dihydroborate (3) (0.5 mmol scale reaction). 
Under anaerobic conditions, to a 40 mL vial were added 12 mL Rma cyt c BORR1 
whole-cell suspension (OD600 = 30), 3 mL glucose solution (250 mM), 
diMeNHC-BH3 solution (125 µL, 2 M in MeCN) and Me-EDA (125 µL, 2 M in 
MeCN). The vial was capped and shaken at 520 rpm in an anaerobic chamber at 
room temperature. After 4 hours, another portion of diMeNHC-BH3 (125 µL, 2 M in MeCN) and 
Me-EDA (125 µL, 2 M in MeCN) were added and the vial was shaken for 8 more hours at 520 
rpm. The reaction mixture was then transferred to a 50 mL Falcon tube and extracted by 30 mL 
3:7 hexanes/EtOAc via vortexing (30 s for three times). Centrifugation (5,000xg, 5 min) was used 
to completely separate the organic and aqueous layers. After removal of the organic layers, two 
additional rounds of extraction were performed. The combined organic extracts were dried over 
anhydrous Na2SO4, concentrated, and purified by flash chromatography (dry loading) with 
EtOAc/hexanes (5% to 60% EtOAc/hexanes gradient) to afford pure organoborane product 3 (79 
mg, 0.376 mmol, 75% yield). The protein concentration of OD600 = 30 whole-cell solution was 
determined to be 10.41 µM by hemochrome assay after cell lysis by sonication. The total turnover 
number for this reaction was 3000. The stereoselectivity of the product was determined as 97.5:2.5 
e.r. by normal-phase chiral HPLC. [α]D23 = + 114.5 (c 0.19, EtOAc). 1H NMR (400 MHz,
Chloroform-d) δ 6.82 (s, 2H), 3.98 – 3.78 (m, 2H), 3.75 (s, 6H), 1.95 – 1.10 (m, 2H), 1.88 (br s,
1H), 1.10 (d, J = 6.2 Hz, 3H), 1.06 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, Chloroform-d) δ
183.5, 120.4, 58.7, 36.2, 30.5, 17.8, 14.6. The boron-bound NHC quarternery carbon was not
resolved; 11B NMR (128 MHz, Chloroform-d) δ ‒24.55 (t, J = 90 Hz).
Biocatalytic synthesis of ethyl 2-((2-methyl-pyridin-1-
yl)boraneyl)propanoate (12) on gram scale. Under anaerobic conditions, to a 
250 mL conical flask were added 50 mL Rma cyt c BORR1 whole-cell solution
(OD600 = 30), glucose (2.6 mL, 1 M), picoline borane (1.4 mL, 2 M in MeCN) 
and Me-EDA (1.4 M in MeCN). The flask was shaken at 240 rpm in an anaerobic 
chamber. At 3 h intervals, two additional batches of whole-cell solution (50 mL), 
glucose (2.6 mL, 1 M), picoline borane (1.4 mL, 2 M in MeCN) and Me-EDA 
(1.4 M in MeCN) were added. The reaction mixture was shaken for a total of 24 hours and then 
divided between six 50 mL Falcon tubes. 25 mL 3:7 hexanes/EtOAc was added to each tube to 
Me
BH2
O
OEt
N
12
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extract the borylation product via vortexing (30 s for three times) and centrifugation (5,000xg, 5 
min). After removal of the organic layers, two additional rounds of extraction were performed. 
The combined organic extracts were dried over anhydrous Na2SO4, concentrated, and purified by 
flash chromatography (dry loading) with EtOAc/hexanes (5% to 40% EtOAc/hexanes gradient) to 
afford pure organoborane product 12 (0.74 g, 3.57 mmol, 42% yield). The protein concentration 
of OD600 = 30 whole-cell solution was determined to be 8.18 µM by hemochrome assay after cell 
lysis by sonication. The total turnover number for this reaction was 2910. The stereoselectivity of 
the product was determined as 96:4 e.r. by normal-phase chiral HPLC. [α]D23 = + 117.2 (c 0.37, 
EtOAc). 1H NMR (400 MHz, Chloroform-d) δ 8.53 (dd, J = 6.0, 1.6 Hz, 1H), 7.84 (td, J = 7.7, 1.7 
Hz, 1H), 7.42 – 7.36 (m, 1H), 7.33 – 7.28 (m, 1H), 3.79 (AB qq, J = 10.8, 7.1 Hz, 2H), 3.30 – 2.15 
(m, 2H), 2.77 (s, 3H), 2.05 – 1.92 (m, 1H), 1.05 (d, J = 6.8 Hz, 3H), 0.94 (t, J = 7.1 Hz, 3H). 13C 
NMR (101 MHz, Chloroform-d) δ 182.13, 157.92, 149.35, 140.26, 127.67, 122.60, 58.83, 32.78, 
22.76, 15.16, 14.61. 11B NMR (128 MHz, Chloroform-d) δ –5.10 (t, J = 103 Hz). 
 Biocatalytic synthesis of (1,3-Dimethyl-1H-imidazol-3-ium-2-yl)(2,2,2-
trifluoro-1-phenylethyl)dihydroborate ((R)-18) at (1 mmol scale reaction). To 
a 250 mL conical flask were added 40 mL Rma cyt c BORP1 whole-cell solution 
(OD600 = 30), glucose (2.6 mL, 1 M), diMeNHC-BH3 (1.2 mL, 0.6 M in MeCN) 
and CF3-DMB (1.0 mL, 0.6 M in MeCN). The flask was shaken at 240 rpm in the 
anaerobic chamber. After 6 hours, another batch of whole-cell solution (40 mL, 
OD600 = 30), glucose (2.6 mL, 1 M), diMeNHC-BH3 (1.2 mL, 0.6 M in MeCN) and CF3-DMB 
(1.0 mL, 0.6 M in MeCN) were added to the reaction mixture. The reaction mixture was shaken 
for a total of 30 hours and then divided between four 50 mL Falcon tubes. 25 mL 3:7 
hexanes/EtOAc was added to each tube to extract the borylation product via vortexing (30 s for 
three times) and centrifugation (5,000xg, 5 min). After removal of the organic layers, two 
additional rounds of extraction were performed. The combined organic extracts were dried over 
anhydrous Na2SO4, concentrated, and purified by silica column chromatography (dry loading) with 
EtOAc/hexanes (5% to 50% EtOAc/hexanes gradient) to afford pure organoborane product (R)-
18 (130 mg, 0.485 mmol, 40% yield). Recovered borane starting material is 82 mg. The yield 
based on consumed starting material is 70%. The protein concentration of OD600 = 30 whole-cell 
solution was determined to be 6.06 µM by hemochrome assay after cell lysis by sonication. The 
total turnover number (TTN) for this reaction was 1000. The stereoselectivity of the product was 
determined as 96:4 e.r. by normal-phase chiral HPLC. [α]D23 = ‒ 81.3 (c 0.67, EtOAc). 1H NMR 
(400 MHz, Chloroform-d) δ 7.23 – 7.05 (m, 5H), 6.76 (s, 2H), 3.52 (s, 6H), 2.90 – 2.60 (m, 1H), 
2.25 – 1.40 (m, 2H); 13C NMR (101 MHz, Chloroform-d) δ 169.1, 143.7 (d, J = 3.5 Hz), 131.4 (q, 
J = 278.0 Hz), 128.4, 128.3, 125.2, 120.8, 43.5, 36.0; 11B NMR (128 MHz, Chloroform-d) δ –
26.72 (t, J = 90 Hz); 19F NMR (282 MHz, Chloroform-d) δ –61.80 (d, J = 13 Hz). 
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IX. Derivatization of Enzymatic Borylation Product (R)-18
(A) Conversion of (R)-18 to the corresponding pinacol boronate ester 19. The protocol
was modified from that reported by Zhou et al.12. To a 40 mL vial with screw cap were added 54 
mg enzymatic product (R)-18 (0.2 mmol) and a stir bar. The vial was evacuated and backfilled 
with argon three times. 4 mL acetonitrile solution of pinacol (33 mg, 0.28 mmol, 1.4 eq.) was 
added to the vial via syringe. The resulting solution was stirred for 5 min for (R)-18 to dissolve, 
followed by the addition of 300 µL of 2 M HCl. The vial was stirred at 40 oC. The reaction can be 
monitored by GC-MS (usual reaction time is 10 - 12 hours) or 19F NMR (19 has a chemical shift 
at δ –62.75 ppm (d, J = 12 Hz)). After reaction completion, 10 µL fluorobenzene was added to the 
reaction mixture. An aliquot of reaction mixture was diluted with CDCl3 to measure the yield via 
19F NMR. The formation of 19 was confirmed by GC-MS, and by conversion of 19 to alcohol 20 
(see section B below). 
(B) Conversion of 19 to alcohol 20. To the reaction mixture obtained after ligand
exchange with pinacol in step A, 5 mL of water was added, and the mixture was extracted with 15 
mL of 1:1 hexanes:EtOAc three times. The solvent was removed under reduced pressure and the 
vial was backfilled with argon. The crude product 19 was dissolved in 15 mL of pentane and passed 
through a syringe filter to remove the insoluble materials. This process was repeated two additional 
times to ensure all soluble materials were extracted. The combined organic extracts were dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. Under argon, THF (1 mL) was 
added to the vial to dissolve the crude product 19 followed by the addition of H2O (1 mL) and 154 
mg of NaBO3•4H2O. The reaction mixture was stirred for 6 hours and extracted with EtOAc (15 
mL) three times. The combined organic extracts were concentrated under reduced pressure and 
purified by flash column chromatography to yield alcohol 20 (0 - 30% hexanes/EtOAc). 27.4 mg 
alcohol 1 was obtained (78% yield). The e.r. was confirmed by chiral GC with FID detector using 
a Chiraldex GTA column (30.0 m × 0.25 mm) (conditions: 120 oC isothermal  at 1.0 mL/min He 
carrier gas flow). Retention time: 7.09 min for R enantiomer, 7.52 min for S enantiomer). This 
compound is known13. 1H NMR (400 MHz, Chloroform-d) δ 7.56 – 7.34 (m, 5H), 5.03 (qd, J = 
6.7, 4.4 Hz, 1H), 2.57 (dd, J = 4.5, 1.5 Hz, 1H) 13C NMR (101 MHz, Chloroform-d) δ 134.3, 130.0, 
129.0, 127.8, 124.6 (q, J = 282.1) Hz, 73.2 (q, J = 32.0 Hz). 19F NMR (282 MHz, Chloroform-d) 
δ –78.40 (d, J = 7 Hz).  
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(C) Conversion of 19 to alcohol 21 via Matteson homologation and oxidation. To the
reaction mixture obtained after ligand exchange with pinacol in step A, 5 mL of water was added 
and the mixture was extracted with 15 mL of 1:1 hexanes:EtOAc three times. The solvent was 
removed under reduced pressure and the vial was backfilled with argon. The crude product 19 was 
dissolved in 15 mL of pentane and passed through a syringe filter to remove the insoluble 
materials. This process was repeated two additional times to ensure all soluble materials were 
extracted. The combined organic extracts were concentrated under reduced pressure. Under argon, 
2 mL of anhydrous THF and dibromomethane (35 µL, 2.5 eq.) were added and the vial was cooled 
in a dry ice/acetone bath. n-BuLi (160 µL, 2.5 M in hexanes, 2.0 eq.) was added dropwise over 30 
min. The solution was allowed to warm to room temperature slowly. The reaction mixture was 
then diluted with 3 mL sat. NH4Cl and extracted with EtOAc (15 mL) for three times. The 
combined organic extracts were dried over anhydrous Na2SO4 and concentrated under reduced 
pressure. The resulting crude mixture was dissolved in THF (1 mL). 1 mL of H2O and 
NaBO3•4H2O (154 mg) were then added and the reaction mixture was stirred for 6 hours. The 
reaction was then extracted with EtOAc. The organic extracts were dried, concentrated under 
reduced pressure, and purified by flash column chromatography to yield alcohol 21 (0 - 30% 
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hexanes/EtOAc). 12.6 mg alcohol 21 was obtained (33% overall yield, 38% for the Matteson 
homologation and oxidation steps). The e.r. was confirmed by chiral GC with FID detector using 
a Chiraldex GTA column (30.0 m × 0.25 mm) (conditions: 110 oC isothermal  at 1.0 mL/min He 
carrier gas flow). Retention time: 11.625 min for S enantiomer, 12.443 min for R enantiomer). 
This compound is known14. 1H NMR (400 MHz, Chloroform-d) δ 7.44 – 7.31 (m, 5H), 4.20 (dd, 
J = 11.7, 5.7 Hz, 1H), 4.04 (dd, J = 11.4, 7.8 Hz, 1H), 3.56 (qdd, J = 9.4, 7.8, 5.8 Hz, 1H), 1.57 (s, 
1H). 13C NMR (101 MHz, Chloroform-d) δ 132.8 (d, J = 2.2 Hz), 129.5, 129.4, 129.0, 126.4 (q, J 
= 280.5 Hz), 61.7 (q, J = 2.9 Hz), 52.9 (q, J = 25.5 Hz). 19F NMR (282 MHz, Chloroform-d) δ –
67.47 (d, J = 9 Hz). 
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X. NMR Spectra
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XI. X-ray Crystallography and the Assignments of Absolute Configuration
For products 3 and 18, 10 mg of pure compound was dissolved in 0.5 mL ethylacetate and 
added to a 4 mL vial, which was then placed in a 20 mL vial containing 10 mL n-pentane. The 20 
mL vial was capped, sealed with parafilm, and left undisturbed for three days at 4 oC. A suitable 
crystal was selected and mounted in a nylon loop in immersion oil. All measurements were made 
on a Bruker photon diffractometer with filtered Cu-Kα radiation. Crystals of compound 12 were 
obtained via slow evaporation of an ethylacetate solution of 12 at room temperature.  
Low-temperature diffraction data (f- and w-scans) were collected on a Bruker AXS D8 
VENTURE KAPPA diffractometer coupled to a PHOTON 100 CMOS detector with Cu Ka 
radiation (l = 1.54178 Å) from an IµS micro-source. The structure was solved by direct methods 
using SHELXS15 and refined against F2 on all data by full-matrix least squares with SHELXL-
201616 using established refinement techniques17. All non-hydrogen atoms were refined aniso-
tropically. Unless otherwise noted, all hydrogen atoms were included into the model at 
geometrically calculated positions and refined using a riding model. The isotropic displacement 
parameters of all hydrogen atoms were fixed to 1.2 times the U value of the atoms they are linked 
to (1.5 times for methyl groups). Compound 18 (sample No. P17253) crystallizes in the monoclinic 
space group P21 with two molecules in the asymmetric unit. The coordinates for the hydrogen 
atoms bound to B1 and B2 were located in the difference Fourier synthesis and refined semi-freely 
with the help of a restraint on the B‒H distance (1.12(4) Å). The crystal was refined as a two-
component twin. 
        The absolute configurations of compounds 3, 12 and 18 were established by anomalous-
dispersion effects using Cu Ka radiation (l = 1.54178 Å). For P17170 (compound 3), the Flack x 
parameter of 0.02(7) was determined using 1062 quotients [(I+)−(I−)]/[(I+)+(I−)]. For P17207 
(compound 18), the Flack x parameter of 0.08(3) was determined using 2543 quotients 
[(I+)−(I−)]/[(I+)+(I−)] and the Hooft y is 0.06(2). For P17253 (a two component twin, compound 
12), the Flack x parameter of 0.07(10) was determined using 2069 quotients [(I+)−(I−)]/[(I+)+(I−)], 
the Hooft y is 0.16(9), and the PLATON P3 is 0.997. The Flack and van Hooft parameters are 
measures of the confidence of the absolute structure determination (zero (within several estimated 
standard deviation) for correct enantiomer, one for incorrect, intermediate for racemic 
twinning)18,19. 
WWW.NATURE.COM/NATURE | 57
SUPPLEMENTARY INFORMATIONRESEARCHdoi:10.1038/nature24996
Crystal data and structure refinement for organoborane 3: 
Identification code  P17170 
Empirical formula  C10 H19 B N2 O2 
Formula weight  210.08 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 7.5635(4) Å a= 90°. 
b = 9.4499(5) Å b= 98.612(2)°. 
c = 8.3935(4) Å g = 90°. 
Volume 593.16(5) Å3 
Z 2 
Density (calculated) 1.176 Mg/m3 
Absorption coefficient 0.643 mm‒1 
F(000) 228 
Crystal size 0.150 x 0.150 x 0.050 mm3 
Theta range for data collection 5.330 to 74.490°. 
Index ranges -9<=h<=9, -11<=k<=11, -10<=l<=9
Reflections collected 11161
Independent reflections 2410 [R(int) = 0.0311]
Completeness to theta = 67.679° 100.0 %
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 1.000 and 0.9210
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 2410 / 1 / 138
Goodness-of-fit on F2 1.075 
Final R indices [I>2sigma(I)] R1 = 0.0285, wR2 = 0.0703 
R indices (all data) R1 = 0.0297, wR2 = 0.0711 
Absolute structure parameter 0.02(7) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.150 and -0.204 e.Å‒3 
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Crystal data and structure refinement for organoborane 18: 
Identification code  p17207 
Empirical formula  C13 H16 B F3 N2 
Formula weight  268.09 
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P 1 21 1 
Unit cell dimensions a = 5.6677(7) Å a= 90° 
b = 15.3928(16) Å b= 98.957(6)° 
c = 15.4429(18) Å g = 90° 
Volume 1330.8(3) Å3 
Z 4 
Density (calculated) 1.338 Mg/m3 
Absorption coefficient 0.920 mm‒1 
F(000) 560 
Crystal size 0.21 x 0.18 x 0.05 mm3 
Theta range for data collection 2.897 to 78.467°. 
Index ranges -7<=h<=7, -19<=k<=19, -19<=l<=19
Reflections collected 53323
Independent reflections 5657 [R(int) = 0.0403]
Completeness to theta = 67.000° 100.0 %
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 1.0000 and 0.8917
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 5657 / 1 / 375
Goodness-of-fit on F2 1.058 
Final R indices [I>2sigma(I)] R1 = 0.0307, wR2 = 0.0757 
R indices (all data) R1 = 0.0318, wR2 = 0.0763 
Absolute structure parameter 0.08(3) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.150 and -0.236 e.Å‒3 
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Crystal data and structure refinement for organoborane 12: 
Identification code  P17253 
Empirical formula  C11 H18 B N O2 
Formula weight  207.07 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 8.0292(3) Å a= 90°. 
b = 19.3346(8) Å b= 106.631(2)°. 
c = 8.0293(3) Å g = 90°. 
Volume 1194.34(8) Å3 
Z 4 
Density (calculated) 1.152 Mg/m3 
Absorption coefficient 0.611 mm‒1 
F(000) 448 
Crystal size 0.250 x 0.200 x 0.100 mm3 
Theta range for data collection 2.285 to 74.659°. 
Index ranges -9<=h<=10, -24<=k<=24, -10<=l<=10
Reflections collected 15764
Independent reflections 4783 [R(int) = 0.0592]
Completeness to theta = 67.679° 100.0 %
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.7538 and 0.6598
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4783 / 5 / 290
Goodness-of-fit on F2 1.109 
Final R indices [I>2sigma(I)] R1 = 0.0592, wR2 = 0.1453 
R indices (all data) R1 = 0.0624, wR2 = 0.1496 
Absolute structure parameter 0.07(10) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.624 and -0.287 e.Å‒3 
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